Get started
AAA

Actuate Therapeutics, Inc.

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

ACTU chart


Full chart

Key stats


Market capitalization
‪167.23 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−24.74 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪5.75 M‬
Beta (1Y)
−1.08

About Actuate Therapeutics, Inc.


Sector
Health Technology
CEO
Daniel M. Schmitt
Headquarters
Fort Worth
Website
actuatetherapeutics.com
Founded
2015
FIGI
BBG00NK7LK03
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

ACTU news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ACTU is 8.30 USD — it has increased by 0.57% in the past 24 hours. Watch Actuate Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Actuate Therapeutics, Inc. stocks are traded under the ticker ACTU.
ACTU stock has risen by 2.34% compared to the previous week, the month change is a 24.64% rise, over the last year Actuate Therapeutics, Inc. has showed a −15.99% decrease.
ACTU reached its all-time high on Aug 15, 2024 with the price of 10.16 USD, and its all-time low was 5.51 USD and was reached on Sep 25, 2024. View more price dynamics on ACTU chart.
See other stocks reaching their highest and lowest prices.
ACTU stock is 10.46% volatile and has beta coefficient of −1.08. Track Actuate Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Actuate Therapeutics, Inc. there?
Yes, you can track Actuate Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
ACTU net income for the last quarter is ‪−6.57 M‬ USD, while the quarter before that showed ‪−8.30 M‬ USD of net income which accounts for 20.78% change. Track more Actuate Therapeutics, Inc. financial stats to get the full picture.
No, ACTU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ACTU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Actuate Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.